Your session is about to expire
← Back to Search
EEG Monitoring for Anesthesia in Aging
N/A
Waitlist Available
Led By Patrick L. Purdon, PhD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Candidates scheduled for open or laparoscopic general surgical procedures under general anesthesia
American Society of Anesthesiologists (ASA) physical status classification of I, II or III
Timeline
Screening 3 weeks
Treatment Varies
Follow Up on postoperative day 1
Awards & highlights
Study Summary
This trial is exploring whether monitoring brain waves could help anesthesiologists deliver anesthesia more precisely, specifically in elderly patients.
Who is the study for?
This trial is for people aged 65 or older who are fluent in English and scheduled for surgery under general anesthesia. They must be generally healthy (ASA I-III) with no cognitive impairment, dementia, severe obesity, MRI contraindications like metal implants, or a history of significant neurological or psychiatric conditions.Check my eligibility
What is being tested?
The study is looking at how brain wave patterns during anesthesia (alpha oscillation dynamics) relate to brain images and aging. Participants will have their EEG monitored during surgery to see if these signals can predict changes in the brain associated with getting older.See study design
What are the potential side effects?
Since this trial involves standard procedures already used in surgeries (EEG monitoring and MRI), side effects are minimal but may include discomfort from wearing the EEG cap or lying still for an MRI scan.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am scheduled for surgery under general anesthesia.
Select...
My overall health is good to moderately impaired.
Select...
I am 65 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ one week before the surgery and postoperative day 7
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one week before the surgery and postoperative day 7
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Intraoperative Burst Suppression Time
Postoperative Cognitive Decline
Postoperative Delirium Incidence
Trial Design
2Treatment groups
Active Control
Group I: Treatment GroupActive Control1 Intervention
Anesthesiologists in the treatment group use the unprocessed EEG waveforms and EEG spectrogram to maintain appropriate levels of unconsciousness for general anesthesia while avoiding burst suppression.
Group II: Control GroupActive Control1 Intervention
Anesthesiologists managing patients assigned to the control group will manage each anesthetic based on their clinical judgment, using standard monitoring required by American Society of Anesthesiologists (ASA), which include cardiac and respiratory monitoring, but not EEG monitoring.
Find a Location
Who is running the clinical trial?
Massachusetts General HospitalLead Sponsor
2,928 Previous Clinical Trials
13,198,331 Total Patients Enrolled
12 Trials studying Aging
1,131 Patients Enrolled for Aging
Patrick L. Purdon, PhDPrincipal InvestigatorMassachusetts General Hospital
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a history of serious brain or psychiatric conditions.I am scheduled for surgery under general anesthesia.My overall health is good to moderately impaired.My BMI is 40 or higher.I am 65 years old or older.I have a hearing or visual impairment.I have been diagnosed with Alzheimer's Disease.
Research Study Groups:
This trial has the following groups:- Group 1: Treatment Group
- Group 2: Control Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any available opportunities to join this research initiative?
"As per the records hosted on clinicaltrials.gov, this research unfortunately is no longer looking for participants as it was last updated in October 2019. Nevertheless, there remain 48 other investigations that are actively recruiting patients at this time."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger